Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 280-734-8 | CAS number: 83763-48-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From Aug. 14, 2006 to Aug. 31, 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
- Reference Type:
- secondary source
- Title:
- Percutaneous absorption of hair dyes: An interlaboratory comparison of in vivo and in vitro data with rat and pig
- Author:
- Beck, H.; Bracher, M.; Bartnik, F. G.
- Year:
- 1 994
- Bibliographic source:
- IN VITRO TOXICOL 7, 305-312
- Reference Type:
- publication
- Title:
- Updated OPINION ON 2-Amino-4-hydroxyethylaminoanisole sulfate
- Author:
- Scientific Committee on Consumer Safety
- Year:
- 2 009
- Bibliographic source:
- European Comission Directorate-General for Health & Consumers
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- Deviations:
- yes
- Remarks:
- Only 8 samples used from 3 donors (instead of 6 required from at least 3 differents donors) but sufficient for OECD TG 428 requirements
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Environmental Health and Safety Publications, series on testing and assessment No. 28. Guidance Document for the conduct of skin absorption studies. Paris, March 2004
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Test Guidelines for In Vitro Assessment of Percutaneous Absorption and Penetration of Cosmetic Ingredients. Colipa Task Force Cutaneous Penetration. Food and Chemical Toxicology 37,191 - 205 (1999)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- according to Swiss Ordinance based on OECD principles of GLP
Test material
- Reference substance name:
- (3-ammonio-4-methoxyphenyl)(2-hydroxyethyl)ammonium sulphate
- EC Number:
- 280-734-8
- EC Name:
- (3-ammonio-4-methoxyphenyl)(2-hydroxyethyl)ammonium sulphate
- Cas Number:
- 83763-48-8
- Molecular formula:
- C9H14N2O2.H2O4S
- IUPAC Name:
- (3-ammonio-4-methoxyphenyl)(2-hydroxyethyl)ammonium sulphate
- Reference substance name:
- Lehmann Blau
- IUPAC Name:
- Lehmann Blau
- Reference substance name:
- 2-amino-4-hydroxyethylaminoanisole sulfate
- IUPAC Name:
- 2-amino-4-hydroxyethylaminoanisole sulfate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- UNLABELLED TEST SUBSTANCE
- Name of test material: Lehmann blue; 2-Amino-4-hydroxyethylaminoanisole sulfate (Code# A000157)
- TSIN: WR23081
- Substance type: Pure active substance
- Physical state: Pale grey powder
- Stability under test conditions: The substance is considered to be stable for more than 12 years if stored dry and protected from light at room temperature
- Stability in solution: Stability of test stock solution (5 weight %) was tested by HPLC over a period of 7 days when the solution is stored at room temperature in the absence of light.
In water: (t = 0h: 100%; 6h: 93.8%; 2d: 95.1%; 7d: 79.7%) low degradation
In DMSO: (t = 0h: 100%; 6h: 98.8%; 2d: 92.0%; 7d: 80.5%) low degradation
- Storage: At room temperature, protected from light and moisture
- Solubility: 10 g/L in water pH 2.8 (>5 weight% pH 8)
1 weight% in acetone/water 1:1 (pH 2.1)
9-10 weight% in DMSO
0.2 weight% in ethanol
LABELLED TEST SUBSTANCE
- Name of test material: [ring-U-14C] Lehmann blue
- Specific activity: 851 MBq/mmol; 23 mCi/mmol
- Storage: - 20˚C in the absence of moisture, light and air
Color cream formulation with 3% 2-Amino-4-hydroxyethylamino-anisole sulfate and equimolar amounts of reaction partner (WR18247)
Identity: Color cream with PyrazoI DHE and Lehmannblau
Batch N°: DTF68081
Recipe N°: 85903070
Appearance of cream formulation: Beige cream
Aggregate state at room temperature: Paste-like
Storage: At room temperature
Supplier: F. Biolley, RD-IPC, COSMITAL SA
Preparation Date: 26.07.2006
Expiration Date: 26.01.2008
Constituent 1
Constituent 2
Constituent 3
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: supplied by the sponsor, batch no. 57
- Expiration date of the lot/batch: July 2005
- Purity test date: 19 February 2004
RADIOLABELLING INFORMATION (if applicable)
- Radiochemical purity: 98.8%
- Specific activity: 10 mCi /mL
- Locations of the label: [U-14C] Uniform labelling of the aromatic ring system
- Expiration date of radiochemical substance: not specified but analysis was performed the 30 May 2006
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: At room temperature, protected from light and moisture
- Stability under test conditions: 82% recovery after 3 days in the receptor fluid
- Solubility and stability of the test substance in the solvent/vehicle: 82.6 mg/ml (pH=7.30) in receptor fluid
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: not applicable
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The color cream formulation containing 1.5% of test substance was prepared by mixing 1.5 g of Color cream formulation (containing 3% of test substance), equimolar amounts of reaction partner (WR18247), 40 µL of partially radiolabeled test substance and 1.5 g of Welloxon Perfect 6%.
- Preliminary purification step (if any): not specified
- Final dilution of a dissolved solid, stock liquid or gel: not specified
- Final preparation of a solid: not detailed
FORM AS APPLIED IN THE TEST (if different from that of starting material) in color cream formulation
TYPE OF BIOCIDE/PESTICIDE FORMULATION (if applicable)
OTHER SPECIFICS: - Radiolabelling:
- yes
- Remarks:
- ring-U-14C
Administration / exposure
- Duration of exposure:
- 30 minutes
- Doses:
- 400 mg of the formulation (100 mg/cm2), containing 1.5% 2-Amino-4-hydroxyethylamino anisole sulfate (1.5 mg of test substance/cm2)
- Details on study design:
- DOSE PREPARATION:
- Method for preparation of dose suspensions: The color cream formulation containing 1.5% of test substance was prepared by mixing 1.5 g of Color cream formulation (containing 3% of test substance), equimolar amounts of reaction partner (WR18247), 40 µL of partially radiolabeled test substance and 1.5 g of Welloxon Perfect 6%.
The detailed composition of color cream formulation is provided in the study report.
APPLICATION OF DOSE: After checking integrity, 12 skin samples were covered with 400 mg of an oxidative hair dye formulation containing 1.5 of test substance on 4 cm2 for 30 minutes in two consecutive series (6 skin samples for each series).
TEST SITE
- Area of exposure: 4 cm2
REMOVAL OF TEST SUBSTANCE
- Washing procedures: The formulation was removed by extensive washing in five steps (2 x 4 mL of water, 1 x 4 mL of shampoo,, 2 x 4 mL of water)
- Time after start of exposure: 30 minutes
SAMPLE COLLECTION
- Spatula: After application of the final formulation, the spatula was dipped into 1 mL of ethanol and rinsed with 4 mL of water. This solution was analyzed for radioactivity.
- Receptor fluid: The receptor fluid was sampled after 16, 24, 40, 48, 64 and 72 hours.
- Rinsings: 15 µL of rinsing solution was used for analysis of test substance content.
- Separation of Skin compartments: After disassembly of the skin samples from the Teflon chambers, the skin samples were wrapped in aluminum foil and put on a hot surface (80 to 90°C) upside down (i.e. lower skin upside) charged with a small weight of approximately 40 g. After 15 to 60 seconds, the packed skin sample was removed from the hot surface and unwrapped. The upper skin was separated from the lower skin using forceps and the two compartments were extracted for analysis.
SAMPLE PREPARATION
- Spatula: The water solution (in which the spatula dipped in ethanol was rinsed) was diluted with 15 mL of scintillation cocktail and the radioactivity was quantified using a scintillation counter.
- Receptor fluid: An aliquot of collected receptor fluid fraction (i.e. 5 mL) was mixed with 15 mL of scintillation cocktail for radioactivity analysis.
- Skin samples: The skin samples were processed as follows:
Extractions of the skin compartments: Each of the skin compartments was dissolved overnight in 2 mL aqueous KOH solution (10M) at 80°C. 200 µL of the resulting solution were mixed with 200 µL of concentrated hydrochloric acid and 3 mL of the scintillation cocktail. The radioactivity was quantified with a scintillation counter.
Extraction of the aluminium foil: After the separation of the skin compartments, the aluminium foil was dipped overnight into 1 mL of a solution containing 5% methanol in water. Thereafter, the aluminum foil was removed and the extract was diluted with scintillation cocktail. The radioactivity was quantified with a scintillation counter.
- Rinsings: 15 µL of each of the rinsing fractions were diluted with 3 mL scintillation cocktail and the radioactivity was quantified.
- Storage procedure: All samples (application formulation, rinsings, receptor fluid fractions and skin compartment extracts) were stored at -20 °C, if not processed immediately. Samples used for the determination of the stability in receptor fluid were stored at room temperature until analysis.
ANALYSIS
- Method type(s) for identification: Liquid scintillation counting (LSC; Packard Tricarb 2250CA)
- Validation of analytical procedure: A calibration curve was established with aliquots of the solution of the radiolabeled test substance. The calibration curve was linear (R2 = 0.9939) up to 1'200'000 dpm.
- Limits of detection and quantification: The limit of detection of test substance is the value for the dpm found for the blank sample. A priori, this value is in the range of 10 to 50 dpm. However 100 dpm may be considered as significant above the background. With respect to the applied formulation containing 1.5% of unlabelled test substance this would correspond to:
Absolute limit of detection [LOD]: 10.14 ng of test substance - Details on in vitro test system (if applicable):
- Two independant experiments were performed with 6 skin samples.
SKIN PREPARATION
- Source of skin: Skin samples from 6 pigs (3 pigs were used in each test series) weighing 110 - 120 kg were obtained from Butchery Kunzli, CH-1724 Praroman-Le-Mouret
- Type of skin: Split thickness skin samples obtained from back and flanks. The preparations were composed of the stratum corneum, the stratum germinativum and part of the dermis containing blood vessels.
- Preparative technique: Dermatome
- Thickness of skin: 0.85 ± 0.16 mm(measured with a micrometer)
- Membrane integrity check: Yes, by tritiated water with scintillation counting of one hour fractions over a time period of four hours.
- Storage conditions: Stored at - 20 °C until use
- Justification of species, anatomical site and preparative technique: Among several animal species, pig skin from flank and back represents a good model for human skin.
PRINCIPLES OF ASSAY
- Diffusion cell: Six permeation chambers (Teflon-chambers) with 9.1 cm2 surface were used. At the beginning of the experiment, thawed skin samples were mounted dermal side down in permation chambers.
- Receptor fluid: Receptor fluid was composed of 0.14 M NaCl, 2 mM K2HPO4, 0.4 mM KH2PO4, 100 IU penicillin/mL, 76 IU streptomycin/mL, 0.3% Ascorbic acid, 0.4% Sodium sulfite and 3% of Ethanol( pH = 7.3)
- Solubility of test substance in receptor fluid: 92.6 mg/mL in receptor fluid
- Stability of test material in receptor fluid: 82% recovery after 3 days (50 mg/mL, in the presence of
0.3% ascorbic acid and 0.4% sodium sulfite}
- Flow-through system: Yes, the experiment was performed using a flow through system with a constant flow of the receptor fluid of 5 mL/h
- Test temperature: 32 ± 2°C
- Relative humidity: 20.5 to 34.9% (first series), 24.9 to 32.2% (second series)
- Occlusion: No
- Reference substance: Yes, mannitol was tested to assess the performance and reliability of the test system.
- Principle diffusion barrier: Stratum corneum was identified as the principal diffusion barrier, the integrity of which was controlled in each experiment by 3H2O penetration characteristics.
Results and discussion
- Absorption in different matrices:
- - Rinsing solution (after 30 minutes): 92.69 ± 3.46% or 1340.92 ± 50.57 µg/cm2; After the removal of applied test substance with water and shampoo after 30 minutes, the recovered test substance was found in majority in the rinsing solutions.
- Receptor fluid: Within 72 hours 0.028 ± 0.015% or 0.409 ± 0.223 µg/cm2 of test substance had penetrated into the receptor fluid.
With respect to the receptor fluid, only small amounts of test substance were detectable within the first fractions collected during 72 hours indicating that no further test substance is available from a potential reservoir of the skin compartments.
- Skin preparations: After 72 hours , small amounts of test substance was found in the upper skin 0.162 ± 0.057% or 2.352 ± 0.824 µg/cm2 and in the lower skin 0.021 ± 0.015% or 0.303 ± 0.219 µg/cm2
Under the assumption that a depot effect is absent, a maximum amount of 0.712 ± 0.313 µg/cm2 of test substance is considered as biologically available (n=8, three donors; receptor fluid + lower skin; 0.409 + 0.303 µg/cm2). - Total recovery:
- - Total recovery: 96.59 ± 3.53% (or 1446.71 ± 7.86 µg/cm2)
- Recovery of applied dose acceptable: Yes
- Results adjusted for incomplete recovery of the applied dose: Yes, total recovery is corrected for losses on tips.
- Limit of detection (LOD): 10.14 ng of test substance as the absolute limit of detection with respect to the applied formulation containing 1.5% test substance.
Percutaneous absorptionopen allclose all
- Dose:
- 100 mg/cm2 formulation containing 1.5% of test substance (1.5 mg /cm2)
- Parameter:
- percentage
- Absorption:
- 0.028 %
- Remarks on result:
- other: 72 hours
- Remarks:
- Absorption in receptor fluid within 72 hours exposure
- Dose:
- 100 mg/cm2 formulation containing 1.5% of test substance (1.5 mg /cm2)
- Parameter:
- percentage
- Absorption:
- 0.021 %
- Remarks on result:
- other: 72 hours
- Remarks:
- Absorption in lower skin after 72 hours exposure
- Key result
- Time point:
- 72 h
- Dose:
- 100 mg/cm2 formulation containing 1.5% of test substance (1.5 mg/cm2)
- Parameter:
- percentage
- Absorption:
- 0.211 %
- Remarks on result:
- other: 72% absorption rate including upper skin, lower skin and receptor fluid
- Key result
- Time point:
- 72 h
- Dose:
- 100 mg/cm2 formulation containing 1.5% of test substance (1.5 mg/cm2)
- Parameter:
- amount
- Absorption:
- 3.065 other: µg/cm2
- Remarks on result:
- other: absorption amount including upper, lower skin and receptor fluid
Any other information on results incl. tables
Reference control: The mean value for the penetration of mannitol through pig skin preparations calculated for all samples was 0.76 ± 0.49% of the applied dose (n=12, water as vehicle).
Skin integrity: The integrity of each skin preparation was determined by examination of penetration characteristics with tritiated water. The skin integrity values for the eight skin samples taken into consideration for the calculation of the mean were within the limit of acceptance (≤ 2.0%).
SCCS Comments
- The amount applied (100 mg/cm²) is very high compared to the normal value of 20 mg/cm².
- The "upper skin" (stratum corneum + upper stratum germinativum) was separated from the "lower skin" (lower stratum germinativum and upper dermis). This does not allow calculating the values in (i) stratum corneum (SC), (ii) epidermis without SC and (iii) dermis separately, as requested by the SCCP.
- The study authors do not consider the amount measured in the "upper skin" as biologically available. However, the "upper skin" contains a large part of the epidermis (not only the stratum corneum), therefore the mentioned value of 0.712 μg/cm² is an underestimation.
- Overall, it is clear that the study authors did not take into account the SCCP requirements (SCCP/0970/06). With only 8 samples in total from 3 donors (instead of the required minimum of 6 evaluable samples, from each of at least 3 donors) and an incorrect separation of the skin, the exact dermal absorption cannot be deduced from this study.
Considering the above, a worst case scenario for dermal absorption of 2-amino-4 - hydroxyethylamino anisole sulfate may be its amount found in the receptor fluid together with its amounts present in the upper as well as in the lower skin. Thus, the dermal absorption of 2-amino-4-hydroxy-ethylamino-anisole sulphate may be considered as 3.064 + 2 x 0.88 = 4.82 μg/cm².
Dermal absorption of 2-amino-4-hydroxy-ethylamino-anisole sulphate
Amount of WR 23081 in: |
µg/cm2(mean ± S.D, n = 8) |
%* (mean ± S.D, n =8 ) |
||||
Receptor fluid (72 hours) |
0.409 |
± |
0.223 |
0.028 |
± |
0.015 |
Lower skin (72 hours) |
0.303 |
± |
0.219 |
0.021 |
± |
0.015 |
Upper skin (72 hours) |
2.352 |
± |
0.824 |
0.162 |
± |
0.057 |
Systemic bioavailability** |
3.064 |
± |
0.88 |
0.211 |
± |
0.061 |
Rinsing solution (after 60 min.) |
1340.92 |
± |
50.57 |
92.69 |
± |
3.46 |
Total balance (recovery)*** |
1446.71 |
± |
7.86 |
96.59 |
± |
3.53 |
* Corrected for individual applied dose;
**sum of receptor fluid + lower skin + upper skin
*** Total is corrected for losses on handling
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this in vitro cutaneous absorption study of 2-Amino-4-hydroxyethylamino anisole sulfate, a maximum amount of 3.065 ± 1.266 µg/cm2 and 0.21 ± 0.087 % of test substance is considered as biologically available (including upper skin, lower skin and receptor fluid).
- Executive summary:
The cutaneous absorption (in-vitro) of 1.5% 2 -Amino-4 -hydroxyethylamino anisole sulfate in a typical hair dye formulation in the presence of hydrogen peroxide and a reaction partner (1-Hydroxyethy1 4,5-Diamino Pyrazole Sulfate) was determined following methods according to the OECD Guideline 428 (Skin Absorption: In Vitro Method).
Pig skin samples (from back and flanks) were used as the test system. Skins from 6 pigs (skin of 3 pigs was used in the 1stseries of experiments and skin of other 3 pigs was used in the 2ndseries of experiments), weighing 110 – 120 kg were obtained from Butchery Kunzli, CH-1724 Praroman-Le-Mouret, Switzerland. Two skin samples were obtained from each pig. In total, 12 skin samples were used in this study.
The integrity of each skin preparation was determined by examination of penetration characteristics with tritiated water. The skin integrity values for the eight skin samples taken into consideration for the calculation of the mean were within the limit of acceptance (≤ 2.0%). After checking the skin integrity, 400 mg of the typical hair dye formulation (100 mg/cm2) containing 1.5% test substance (i.e. 1.5 mg/cm2) was applied to 12 skin samples for 30 minutes in two independent experiments including 6 skin samples each. After completion of exposure period, the samples were washed off with water and shampoo and the amount of test substance in the rinsing solutions was determined.
The receptor fluid was sampled at 16, 24, 40, 48, 64 and 72 hour intervals to determine the test substance concentration. At the termination of the experiment, the skin was heat-treated to separate the upper and lower skin compartments. The different matrices (rinsing solution, receptor fluid, lower skin and upper skin) were processed and analyzed by means of a scintillation counter to determine radioactive concentrations.
The majority of the test substance was recovered in the rinsing solutions (92.69 ± 3.46% or 1340.92 ± 50.57 µg/cm2) after 30 minutes. Small amounts of test substance were detected in the upper skin (0.162 ± 0.057% or 2.352 ± 0.824 µg/cm2), in the lower skin (0.021 ± 0.015% or 0.303 ± 0.219 µg/cm2) and in the fractions of the receptor fluid collected within 72 hours (0.028 ± 0.015% or 0.409 ± 0.223 µg/cm2).
The mass balance (total recovery) was 96.59 ± 3.53% (or 1446.71 ± 7.86 µg/cm2) of the dose applied to the pig skin samples.
With respect to the receptor fluid, only small amounts of test substance were detectable within the first fractions collected during 72 hours indicating that no further test substance is available from a potential reservoir of the skin compartments. With such an absorption profile, it was assumed that a depot effect is absent.
Under the conditions of this in vitro cutaneous absorption study of 2-Amino-4-hydroxyethylamino anisole sulfate, a maximum amount of 3.065 ± 1.266 µg/cm2 and 0.21 ± 0.087 % of test substance is considered as biologically available (including upper skin, lower skin and receptor fluid).
This cutaneous absorption (in vitro) study is classified as acceptable, and satisfies the guideline requirements of the OECD 428 method.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.